Strategic Blueprint’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $471K | Buy |
6,028
+2,397
| +66% | +$187K | 0.02% | 456 |
|
|
2025
Q1 | $263K | Buy |
3,631
+893
| +33% | +$64.7K | 0.01% | 571 |
|
|
2024
Q4 | $203K | Buy |
+2,738
| New | +$203K | 0.01% | 631 |
|
|
2022
Q2 | – | Sell |
-2,970
| Closed | -$350K | – | 495 |
|
|
2022
Q1 | $350K | Buy |
2,970
+442
| +17% | +$52.1K | 0.04% | 353 |
|
|
2021
Q4 | $328K | Buy |
2,528
+601
| +31% | +$78K | 0.04% | 360 |
|
|
2021
Q3 | $218K | Sell |
1,927
-1,469
| -43% | -$166K | 0.03% | 368 |
|
|
2021
Q2 | $352K | Sell |
3,396
-468
| -12% | -$48.5K | 0.06% | 276 |
|
|
2021
Q1 | $323K | Buy |
3,864
+130
| +3% | +$10.9K | 0.07% | 229 |
|
|
2020
Q4 | $341K | Sell |
3,734
-1,975
| -35% | -$180K | 0.09% | 174 |
|
|
2020
Q3 | $456K | Buy |
+5,709
| New | +$456K | 0.14% | 127 |
|
|
2019
Q4 | – | Sell |
-2,565
| Closed | -$188K | – | 194 |
|
|
2019
Q3 | $188K | Buy |
+2,565
| New | +$188K | 0.14% | 69 |
|